Vera Therapeutics Inc VERA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
40.87UNCH (UNCH)
Volume
6,828
Close
40.87quote price arrow up+0.12 (+0.29%)
Volume
366,538
52 week range
7.10 - 50.78
Loading...
  • Open40.88
  • Day High41.52
  • Day Low40.37
  • Prev Close40.75
  • 52 Week High50.78
  • 52 Week High Date03/01/24
  • 52 Week Low7.10
  • 52 Week Low Date05/26/23

Key Stats

  • Market Cap2.225B
  • Shares Out54.45M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change165.73

KEY STATS

  • Open40.88
  • Day High41.52
  • Day Low40.37
  • Prev Close40.75
  • 52 Week High50.78
  • 52 Week High Date03/01/24
  • 52 Week Low7.10
  • 52 Week Low Date05/26/23
  • Market Cap2.225B
  • Shares Out54.45M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change165.73

RATIOS/PROFITABILITY

  • EPS (TTM)-2.04
  • P/E (TTM)-20.01
  • Fwd P/E (NTM)-18.08
  • EBITDA (TTM)-101.866M
  • ROE (TTM)-36.89%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)14.16%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vera Therapeutics Inc

 

Profile

MORE
Vera Therapeutics, Inc. is a late-stage biotechnology company. The Company is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its product candidate, atacicept, is a self-administered fusion protein that blocks both a B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) which stimulates B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. The...
Michael Morrissey Ph.D.
Independent Non-Executive Chairman of the Board
Marshall Fordyce M.D.
President, Chief Executive Officer, Founder, Director
Sean Grant
Chief Financial Officer
Address
8000 Marina Boulevard,, Suite 120
Brisbane, CA
94005
United States

Top Peers

SYMBOLLASTCHG%CHG
GERN
Geron Corp
3.68-0.06-1.60%
DYN
Dyne Therapeutics Inc
28.16+1.54+5.79%
RCKT
Rocket Pharmaceuticals Inc
23.38+0.29+1.26%
RNA
Avidity Biosciences Inc
28.91+2.89+11.11%
KROS
Keros Therapeutics Inc
52.80-1.20-2.22%